Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids

BACKGROUND: High dose intravenous glucocorticoid (ivGC) therapy is the first line treatment in moderate to severe Graves’ ophthalmopathy (GO) and is associated with a clinical response rate ranging from 50% to 80%. Recently, a positive correlation between total cholesterol and low-density lipoprotei...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Autores principales: Naselli, Adriano, Moretti, Diletta, Regalbuto, Concetto, Arpi, Maria Luisa, Lo Giudice, Fabrizio, Frasca, Francesco, Belfiore, Antonino, Le Moli, Rosario
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7784376/
https://ncbi.nlm.nih.gov/pubmed/33414766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.609895
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares